Tim Kelsey Leaves HIMSS and Takes Over PKS As CEO.

This release appeared an hour or so ago.

06 Oct 2020 9:59 AM AEST  

PKS appoints internationally regarded digital health expert, Tim Kelsey as new CEO             

The Board of PKS Holdings Limited (ASX: PKS) (“PKS” or the “Company”), an Australian pioneer of advanced data services in healthcare, is pleased to announce the appointment of data analytics and digital transformation expert, Tim Kelsey as the new Chief Executive Officer (CEO) to lead the next phase of growth. The Company’s current Managing Director, Ron van der Pluijm will support Tim throughout the transition and continue in his role as non-executive Director. 

·         Internationally regarded leader in digital health strategies and former CEO of Australian Digital Health Agency, NHS National Director for Patients and Information; 

·         A clear global understanding of healthcare analytics (former Chair of the Global Digital Health Partnership involving 30 governments and the World Health Organisation);  

·         Entrepreneurial experience in building analysis and publication of patient outcomes for Dr Foster in the UK, named UK’s top 10 fastest growing companies in 2006; and 

·         Most recently serving as Senior Vice President of HIMSS Analytics International (Healthcare Information Management Systems Society), an organisation which measures impacts of digital health programs to improve clinical, social and economic outcomes in more than 50 countries.

PKS Chair, Mr Mike Hill said: ‘We are delighted to appoint Tim as chief executive – he has a proven track record for growth and delivery as a private sector entrepreneur and a public service leader. He is a highly regarded expert in data analytics and broader digital health services both in Australia and internationally. Tim’s appointment was the culmination of an extensive CEO succession planning process. The Board is deeply appreciative of the outstanding leadership Ron has provided PKS as it has become a growing public company with a solid foundation for significant growth. Tim has an outstanding network of high profile global healthcare decision makers in both the private and public sectors. He will be a highly capable successor as we continue to accelerate our strategy, expand the business internationally, scale up the sales and marketing functions and continue to develop globally leading products.”

 Mr van der Pluijm said: “The listing of PKS, renegotiation of various major agreements including with Abbott and the transformational acquisition of Pavilion Heath have been some of my proudest achievements in my career. However, I believe it is now the right time to hand over the management of the Company’s next stage of growth to Tim. PKS as a company has a very strong value proposition and I will continue to assist Tim and the executive team with a smooth transition period as a non-executive Director. I look forward to being a part of and watching PKS’ future successes.”

The Board looks forward to working closely with Tim to accelerate the delivery of our strategy and to continue to drive organic growth whilst pursuing additional acquisition opportunities. Tim's start date is to be confirmed but will be prior to the end of calendar 2020. 

- ENDS - 

For further information please contact:

Jane Morgan Management

Investor and Media Relations

lexi@janemorganmanagement.com.au

+61 404 57 076

---- End Release

An interesting choice to join a company with market cap. of less that $50M and a net profit of less that $400,000. Total revenue is less than $8 Million. Really a tiddler!

More info is found here:

https://pks.com.au/

Enjoy!

David.